News & Media

Media Release

Date: 3 December 2020

RUH plays important role in new COVID-19 vaccine study

Researchers at the Royal United Hospitals Bath NHS Foundation Trust (RUH) are playing an important role in a new worldwide COVID-19 vaccine study.

Volunteers from across the West of England are being called on to join up to 30,000 more to test the safety and effectiveness of a new vaccine candidate developed by the Janssen Pharmaceutical Companies of Johnson & Johnson.

Dr Kelly Spencer PhD, RUH Research Manager – Operations said: "The RUH being part of this important trial, and others in the future, provides an excellent opportunity for staff and residents within our local communities to support the ongoing efforts to put an end to this pandemic. The more COVID vaccines we can develop, the quicker they can be rolled out, both here in the UK and internationally, to ensure that all communities have equal access to a lifesaving vaccination.

"The RUH will be responsible for the ongoing monitoring and follow-up of trial participants within our local area. This will involve appointments every few months to test antibody levels in blood, collect information on any side effects and detect whether or not individuals have been infected/in contact with the virus."

If you are interested in taking part in the study go to gb.ensemblestudy.com

ENDS

Download printable version

back to top